PO04 SARS-CoV-2 Vaccinations and Risk of Venous Thrombosis - Case Control Study

Willian van Dijk; Aydın Kant; Frits R. Rosendaal; Astrid van Hylckama Vlieg

doi:10.1016/j.rpth.2023.101966

Related publications

Article2018

Factor V Levels and Risk of Venous Thrombosis: The MEGA Case-Control Study

I.M. Rietveld, Mettine H.A. Bos, W.M. Lijfering, Ruifang Liu, Frits R. Rosendaal, Pieter H. Reitsma

Journal of Vascular Surgery Venous and Lymphatic Disorders

Article2013

MEGA case-control study Protein S levels and the risk of venous thrombosis: results from the

Carine J.M. Doggen, Willem M. Lijfering, Pieter H. Reitsma, Frits R. Rosendaal, Maria Carolina Pintão, Daniel Dias Ribeiro, Irene D. Bezemer, Andrea Aparecida Garcia

Letter2012

Pneumonia and risk of venous thrombosis: results from the MEGA study

Daniel Dias Ribeiro, Willem M. Lijfering, Astrid van Hylckama Vlieg, Frits R. Rosendaal, Suzanne C. Cannegieter

Journal of Thrombosis and Haemostasis

Article2011

Malignancies and risk of recurrent venous thrombosis

J.F. Timp, Linda E. Flinterman, Astrid van Hylckama Vlieg, Frits R. Rosendaal, Suzanne C. Cannegieter

Article2001

Incidence and risk factors of venous thrombosis: a prospective follow-up study

T.J. Visser, Frits R. Rosendaal